Nordic Issuing

Ongoing case

CS Medica A/S

Back to all cases

CS Medica A/S

17 Aug - 31 Aug 2021IPO

CS Medica A / S is a Danish medical company founded in 2011.

The company is committed to developing, manufacturing, and commercializing over-the-counter (OTC) products for medical devices and cosmetics that contain cannabinoids (such as CBD, CBG, and CBN). The company currently focuses on 20 products that contain cannabidiol (CBD) for autoimmune diseases such as the treatment of psoriasis, arthritis and stress-related symptoms such as hair loss.

Read more at the company's website

The offer in summary

Subscription period: 17 August - 31 August 2021

Subscription price: 38.50 DKK per unit

Minimum subscription: 120 units, corresponding to 4,620.00 DKK

Issue volume: 18,033,400.00 DKK

Valuation (pre-money): 61.6 MDKK

Planned first day of trading: 14 September 2021

Unit: One (1) unit consists of five (5) shares and three (3) warrants of series TO 1

Warrant of series TO 1: One (1) warrant of series TO 1 gives the holder a right to subscribe for one (1) new share in the Company during 1-15 of July 2022 at a price of 9,30 DKK per share.

ISIN-codes: Temporary ISIN ("BTU"): DK0061669975 Permanent ISIN share: DK0061668225 Permanent ISIN warrant: DK0061668308

Subscription of units in the IPO shall be made through your bank.

Danish investors can subscribe via Nordnet, Nordea and Arbejdernas Landsbank.


  Prospectus Teaser


Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.